MTOR and malignant peripheral nerve sheath tumor: Recent preclinical studies suggest inhibition of phosphatidylinositol 3-kinase (PI3 K)/AKT and mTOR pathway as a potential therapeutic approach for patients harbouring MPNST [17, 18].